CliffBio
small molecule

IFEX/MESNEX KIT

IFOSFAMIDE; MESNA

Loss of exclusivity—loss of exclusivity
CompanyBaxter Healthcare Corp →See this company's full patent-cliff portfolio

Drug detail

Brand nameIFEX/MESNEX KIT
Active ingredientIFOSFAMIDE; MESNA
Strength3GM/VIAL;100MG/ML
Dosage formINJECTABLE
RouteINJECTION
ModalitySmall molecule
FDA approvalOctober 1992
Marketing statusDISCN

More from Baxter Healthcare Corp

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.